{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-037635","form_type":"8-K","ticker":null,"cik":"0001121702","company_name":"YIELD10 BIOSCIENCE, INC.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.445476+00:00","generated_at":"2026-06-04T08:58:40.914586+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Yield10 Bioscience induces exercise of 3.19M warrants at $0.43/share, issues 6.38M new warrants","bullets":["Existing institutional investors exercise 3,191,140 warrants for cash at reduced exercise price of $0.43 per share.","Company issues new unregistered warrants to purchase up to 6,382,280 shares (200% of exercised shares) at $0.43/share.","New warrants exercisable for five years from shareholder approval date, subject to 9.99% beneficial ownership limitation.","Company to seek shareholder approval within 90 days for issuance of new warrants and underlying shares.","Maxim Group LLC acting as warrant solicitation agent; receives 7.0% cash fee on total proceeds from exercised warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-037635","json":"https://secwatch.observer/filing/0001104659-24-037635.json","markdown":"https://secwatch.observer/filing/0001104659-24-037635.md","text":"https://secwatch.observer/filing/0001104659-24-037635.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/0001104659-24-037635-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/tm249553d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:58:40.914586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"303bb3dfa87c2f2c2e51a971ec1b404e63682406","claim":"YIELD10 BIOSCIENCE, INC. entered into Agreements with certain existing institutional investors (effective 2024-03-22).","evidence_excerpt":"On March 22, 2024, Yield10 Bioscience, Inc., a Delaware corporation (the “ Company ”), entered into warrant exercise agreements (the “ Agreements ”) with certain existing institutional investors","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924037635/0001104659-24-037635-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain existing institutional investors"},{"label":"Effective","value":"2024-03-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}